Therapeutic effect of intravenous sodium thiosulfate for uremic pruritus in hemodialysis patients

References

• Shafiee MA, Akbarian F, Memon KK, et al. Dermatologic manifestations in end-stage renal disease. Iran J Kidney Dis. 2015;9(5):339–353.
   PubMed Web of Science ®Google Scholar
• Hu T, Wang B, Liao X, et al. Clinical features and risk factors of pruritus in patients with chronic renal failure. Exp Ther Med. 2019;18(2):964–971.
   PubMed Web of Science ®Google Scholar
• Rayner HC, Larkina M, Wang M, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000–2007.
   PubMed Web of Science ®Google Scholar
• Chiu YL, Chen HY, Chuang YF, et al. Association of uremic pruritus with inflammation and hepatitis infection in haemodialysis. Nephrol Dial Transplant. 2008;23(11):3685–3689.
   PubMed Web of Science ®Google Scholar
• Grochulska K, Ofenloch RF, Mettang T, et al. Mortality of haemodialysis patients with and without chronic itch: a follow-up study of the German Epidemiological Hemodialysis Itch Study (GEHIS). Acta Derm Venereol. 2019;99(4):423–428.
   PubMed Web of Science ®Google Scholar
• Darrieurtort-Laffite C, Bertrand-Vasseur A, Garraud T, et al. Tolerance and effect of sodium thiosulfate in calcific tendinitis of the rotator cuff. Clin Rheumatol. 2020;39(2):561–569.
   PubMed Web of Science ®Google Scholar
• Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial. 2010;23(3):258–262.
   PubMed Web of Science ®Google Scholar
• Monney P, Nguyen QV, Perroud H, et al. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant. 2004;19(8):2130–2132.
   PubMed Web of Science ®Google Scholar
• Riemer CA, El-Azhary RA, Wu KL, et al. Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review. Br J Dermatol. 2017;177(6):1510–1518.
   PubMed Web of Science ®Google Scholar
• Fares I, Bouattar T, Kone HM, et al. Calciphylaxis: successful management of a rare complication of chronic kidney disease in two patients. Case Rep Nephrol. 2019;2019(2019):1630613.
   PubMedGoogle Scholar
• Burja S, Jovic A, Ekart R, et al. Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcification. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(1):37–40.
   PubMed Web of Science ®Google Scholar
• Musso GG, Enz P, Vidal F, et al. Use of sodium thiosulfate in the treatment of calciphylaxis. Saudi J Kidney Dis Transpl. 2009;20(6):1065–1068.
   PubMedGoogle Scholar
• Schlieper G, Brandenburg V, Ketteler M, et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol. 2009;5(9):539–543.
   PubMed Web of Science ®Google Scholar
• Gu DC. Comparative study of sodium thiosulfate and tacrolimus in the treatment of hormone-dependent dermatitis. China Prac Med. 2018;13(15):142–143.
   Google Scholar
• Ou BS, Liu WB, Li ML. Compound zaoren capsules combined with intravenous sodium thiosulfate for treatment of senile skin pruritus. Prac J Med Pham. 2006;23(1):80.
   Google Scholar
• Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39(4):690–701.
   Web of Science ®Google Scholar
• Hunt GM, Ryder HF. Metabolic acidosis after sodium thiosulfate infusion and the role of hydrogen sulfide. Clin Case Rep. 2018;6(8):1595–1599.
   PubMed Web of Science ®Google Scholar
• Qi XY, Li JF, Liang ZA, et al. Study on the treatment of pruritus in maintenance hemodialysis patients with sodium thiosulfate. Heilongjiang Med. 2019;43(05):474–475.
   Google Scholar
• Liu Y, Zhao B, Liu LF, et al. Clininal effect of sodium thiosulfate in hemodialysis patients with refractory skin itch. J Clin Nephrol. 2020;20(3):194–197.
   Google Scholar
• Li WH, Yin YM, Chen H, et al. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus. Medicine. 2017;96(12):e6160.
   PubMed Web of Science ®Google Scholar
• Coulibaly N, Traoré B, Tounkara AA, et al. Pruritus in chronic hemodialysis patients in the nephrology department of the Point G University Hospital (Bamako-MALI). Med Sante Trop. 2019;29(1):102–105.
   PubMed Web of Science ®Google Scholar
• Panchal S, Holtermann K, Trivedi N, et al. Calciphylaxis: an analysis of concomitant factors, treatment effectiveness and prognosis in 30 patients. Int J Nephrol Renovasc Dis. 2020;13(13):65–71.
   PubMedGoogle Scholar
• Kuypers DR. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol. 2009;5(3):157–170.
   PubMedGoogle Scholar
• Salanova Villanueva L, Sánchez González MC, Sánchez Tomero JA, et al. Successful treatment with sodium thiosulfate for calcific uraemic arteriolopathy. Nefrologia. 2011;31(3):366–368.
   PubMed Web of Science ®Google Scholar
• Ozen N, Cinar FI, Askin D, et al. Uremic pruritus and associated factors in hemodialysis patients: a multi-center study. Kidney Res Clin Pract. 2018;37(2):138–147.
   PubMed Web of Science ®Google Scholar
• Hajheydari Z, Makhlough A. Cutaneous and mucosal. manifestations in patients on maintenance hemodialysis: a study of 101 patients in Sari. Iran J Kidney Dis. 2008;2(2):86–90.
   PubMedGoogle Scholar
• Blaha T, Nigwekar S, Combs S, et al. Dermatologic manifestations in end stage renal disease. Hemodial Int. 2019;23(1):3–18.
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Weiss M, Passlick-Deetjen J, et al. Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch – results from a representative cross-sectional study. BMC Nephrol. 2015;16(1):84.
   PubMedGoogle Scholar
• Hsu CW, Weng CH, Chan MJ, et al. Association between serum aluminum level and uremic pruritus in hemodialysis patients. Sci Rep. 2018;8(1):17251.
   PubMedGoogle Scholar
• Keithi-Reddy SR, Patel TV, Armstrong AW, et al. Uremic pruritus. Kidney Int. 2007;72(3):373–377.
   PubMed Web of Science ®Google Scholar
• Kurban MS, Boueiz A, Kibbi AG. Cutaneous manifestations of chronic kidney disease. Clin Dermatol. 2008;26(3):255–264.
   PubMed Web of Science ®Google Scholar
• Akhyani M, Ganji MR, Samadi N, et al. Pruritus in hemodialysis patients. BMC Dermatol. 2005;5(5):7.
   PubMedGoogle Scholar
• Kimata N, Fuller DS, Saito A, et al. Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Hemodial Int. 2014;18(3):657–667.
   PubMed Web of Science ®Google Scholar
• Orasan OH, Saplontai AP, Cozma A, et al. Insomnia, muscular cramps and pruritus have low intensity in hemodialysis patients with good dialysis efficiency, low inflammation and arteriovenous fistula. Int Urol Nephrol. 2017;49(9):1673–1679.
   PubMed Web of Science ®Google Scholar
• Pisoni RL, Wikström B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–3505.
   PubMed Web of Science ®Google Scholar
• Mahmudpour M, Roozbeh J, Raiss Jalali GA, et al. Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients. Iran J Kidney Dis. 2017;11(1):50–55.
   PubMed Web of Science ®Google Scholar
• Hu X, Sang Y, Yang M, et al. Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients: a meta-analysis of cross-sectional studies. Medicine. 2018;97(21):e10633.
   PubMed Web of Science ®Google Scholar
• Rehman IU, Lai PS, Kun LS, et al. Chronic kidney disease-associated pruritus and quality of life in Malaysian patients undergoing hemodialysis. Ther Apher Dial. 2020;24(1):17–25.
   PubMed Web of Science ®Google Scholar
• Eusebio-Alpapara KMV, Castillo RL, Dofitas BL. Gabapentin for uremic pruritus: a systematic review of randomized controlled trials. Int J Dermatol. 2020;59(4):412–422.
   PubMed Web of Science ®Google Scholar
• Legroux-Crespel E, Clèdes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology. 2004;208(4):326–330.
   PubMed Web of Science ®Google Scholar
• Araya CE, Fennell RS, Neiberger RE, et al. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1(6):1161–1166.
   PubMed Web of Science ®Google Scholar
• Hayden MR, Tyagi SC, Kolb L, et al. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol. 2005;4(4):4.
   PubMedGoogle Scholar
• Datzmann T, Hoffmann A, McCook O, et al. Effects of sodium thiosulfate (Na2S2O3) during resuscitation from hemorrhagic shock in swine with preexisting atherosclerosis. Pharmacol Res. 2020;151:104536.
   PubMed Web of Science ®Google Scholar
• Yu Z, Gu L, Pang H, et al. Sodium thiosulfate: an emerging treatment for calciphylaxis in dialysis patients. Case Rep Nephrol Dial. 2015;5(1):77–82.
   PubMed Web of Science ®Google Scholar
• Pasch A, Schaffner T, Huynh-Do U, et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008;74(11):1444–1453.
   PubMed Web of Science ®Google Scholar
• Goossens J, Courbebaisse M, Caudron E, et al. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases. Semin Arthritis Rheum. 2017;47(3):451–455.
   PubMed Web of Science ®Google Scholar
• Isoherranen K, Bouchard L, Kluger N. Benefits of intralesional injections of sodium thiosulfate in the treatment of calciphylaxis. Int Wound J. 2017;14(6):955–959.
   PubMed Web of Science ®Google Scholar
• Santos PW, He J, Tuffaha A, et al. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy. Int Urol Nephrol. 2017;49(12):2247–2256.
   PubMed Web of Science ®Google Scholar
• O’Neill WC. Sodium thiosulfate: mythical treatment for a mysterious disease? Clin J Am Soc Nephrol. 2013;8(7):1068–1069.
   PubMed Web of Science ®Google Scholar
• Peng T, Zhuo L, Wang Y, et al. Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients. Nephrology. 2018;23(7):669–675.
   PubMed Web of Science ®Google Scholar
• Rehman IU, Chan KG, Munib S, et al. The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan: a STROBE complaint cross-sectional study. Medicine. 2019;98(36):e16812.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Pai AB, Mueller B, et al. Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model. PLoS One. 2019;14(11):e0224767.
   PubMed Web of Science ®Google Scholar
• Mao M, Lee S, Kashani K, et al. Severe anion gap acidosis associated with intravenous sodium thiosulfate administration. J Med Toxicol. 2013;9(3):274–277.
   PubMedGoogle Scholar